FNDC5 and polycystic ovary syndrome: However, Oliveira and co-workers [93] showed that short-term treatment with this anti-diabetic drug (at 1500 mg/day for 60 days) could not affect BAT activity and plasma irisin levels in women with polycystic ovary syndrome.